Education
About Us
Working with TipRanks
Follow Us
Xlife Sciences Ltd. (CH:XLS)
:XLS
XLS Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF16.55 - CHF38.00
Previous CloseN/A
Volume11.21K
Average Volume (3M)1.56K
Market Cap
CHF111.39M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)3.2
Beta0.51
Next Earnings
Sep 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.00
Shares Outstanding5,741,772
10 Day Avg. Volume1,426
30 Day Avg. Volume1,556
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Xlife Sciences Ltd. News
PremiumCompany Announcements
VERAXA Biotech AG Advances Towards NASDAQ Listing with Key Milestone
PremiumCompany Announcements
Xlife Sciences AG Announces Successful Meeting and Future Growth Plans
PremiumCompany Announcements
Xlife Sciences Enters Gene Therapy Market with Strategic Collaboration
PremiumCompany Announcements
Xlife Sciences AG Reports Strategic Growth and Technological Advances in 2024
PremiumCompany Announcements
Xlife Sciences’ VERAXA Biotech to Merge with Voyager Acquisition Corp.Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.80% Public Companies and
Individual Investors
XLS FAQ
What was Xlife Sciences Ltd.’s price range in the past 12 months?
Xlife Sciences Ltd. lowest stock price was CHF16.55 and its highest was CHF38.00 in the past 12 months.
What is Xlife Sciences Ltd.’s market cap?
Xlife Sciences Ltd.’s market cap is CHF111.39M.
When is Xlife Sciences Ltd.’s upcoming earnings report date?
Xlife Sciences Ltd.’s upcoming earnings report date is Sep 23, 2025 which is in 66 days.
How were Xlife Sciences Ltd.’s earnings last quarter?
Currently, no data Available
Is Xlife Sciences Ltd. overvalued?
According to Wall Street analysts Xlife Sciences Ltd.’s price is currently Overvalued.
Does Xlife Sciences Ltd. pay dividends?
Xlife Sciences Ltd. does not currently pay dividends.
What is Xlife Sciences Ltd.’s EPS estimate?
Xlife Sciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xlife Sciences Ltd. have?
Xlife Sciences Ltd. has 5,741,772 shares outstanding.
What happened to Xlife Sciences Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Xlife Sciences Ltd.?
Currently, no hedge funds are holding shares in CH:XLS
Company Description
Xlife Sciences Ltd.
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.
Technical Analysis
Molecular Partners AG
―
Basilea Pharmaceutica
―
Idorsia Ltd
―
Newron Pharmaceuticals SpA
―
Santhera Pharmaceuticals Holding
―